Suchergebnisse - "Hollander, Priscilla A"

PubPharm (41)

1

The Use of Rescue Insulin in the Glycemia Reduction Approaches in Diabetes : A Comparative Effectiveness Study (GRADE)

enthalten in: Diabetes care | 2024

von Hollander, P. | Krause-Steinrauf, H. | Butera, N. | +112

2

Association of Baseline Factors With Glycemic Outcomes in GRADE : A Comparative Effectiveness Randomized Clinical Trial

enthalten in: Diabetes care | 2024

von Garvey, W. | Cohen, R. | Butera, N. | +112

3

Optimization of Metformin in the GRADE Cohort : Effect on Glycemia and Body Weight

enthalten in: Diabetes care | 2020

von Sivitz, W. | Phillips, L. | Wexler, D. | +114

4

Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self-titrating insulin glargine U-100

enthalten in: Diabetes, obesity & metabolism | 2019

von Hollander, P. | Kiljanski, J. | Spaepen, E. | +1

5

Risk of clinically relevant hypoglycaemia in patients with type 2 diabetes self‐titrating insulin glargine U‐100

enthalten in: Diabetes, Obesity and Metabolism | 2019

von Hollander, P. | Kiljanski, J. | Spaepen, E. | +1

6

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes : A randomized, open-label clinical trial

enthalten in: Diabetes, obesity & metabolism | 2018

von Hollander, P. | Carofano, W. | Lam, R. | +8

7

Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes : A randomized, open-label clinical trial

enthalten in: Diabetes, obesity & metabolism | 2018

von Home, P. | Lam, R. | Carofano, W. | +7

8

Similar Efficacy and Safety of Basaglar® and Lantus® in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years) : A Post Hoc Analysis from the ELEMENT-2 Study

enthalten in: Diabetes therapy : research, treatment and education of diabetes and related disorders | 2018

von Pollom, R. | Costigan, T. | Lacaya, L. | +2

9

Similar Efficacy and Safety of $ Basaglar^{®} $ and $ Lantus^{®} $ in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study

enthalten in: Diabetes therapy | 2018

von Pollom, R. | Costigan, T. | Lacaya, L. | +2

10

Similar Efficacy and Safety of $ Basaglar^{®} $ and $ Lantus^{®} $ in Patients with Type 2 Diabetes in Age Groups (< 65 Years, ≥ 65 Years): A Post Hoc Analysis from the ELEMENT-2 Study

enthalten in: Diabetes therapy | 2018

von Pollom, R. | Costigan, T. | Lacaya, L. | +2

1
2
3
4
5
Nächster »
[5]